Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract
The authors develop a mouse model of Enterococcus faecalis colonization to show that enterococci harbouring the bacteriocin-expressing plasmid pPD1 replace indigenous enterococci and have the ability to transfer the plasmid to other enterococci, which enhances the stability of the bacteriocin-expres...
Gespeichert in:
Veröffentlicht in: | Nature (London) 2015-10, Vol.526 (7575), p.719-722 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The authors develop a mouse model of
Enterococcus faecalis
colonization to show that enterococci harbouring the bacteriocin-expressing plasmid pPD1 replace indigenous enterococci and have the ability to transfer the plasmid to other enterococci, which enhances the stability of the bacteriocin-expressing bacteria in the gut; this result suggests a therapeutic approach that leverages niche-specificity to eliminate antibiotic-resistant bacteria from infected individuals.
Competition defeats multidrug-resistant bacteria
Enterococcus faecalis
is a normal gut bacterium and is usually harmless, but it can cause a variety of hospital-acquired infections in which its acquisition of antibiotic resistance makes it hard to treat. Nita Salzman and colleagues develop a mouse model of
E. faecalis
infection and use it to show that enterococci harbouring the bacteriocin-expressing plasmid pPD1 replace indigenous enterococci and have the ability to transfer the plasmid to other enterococci, thereby enhancing the stability of the bacteriocin-expressing bacteria in the gut. However, colonization by a strain in which the plasmid was not passed on resulted in clearance of other enterococci strains from the gut — including those resistant to the antibiotic vancomycin. This result suggests a way of using bacteriocin-producing bacteria as targeted therapeutics designed to clear competing multidrug-resistant strains from infected individuals.
Enterococcus faecalis
is both a common commensal of the human gastrointestinal tract and a leading cause of hospital-acquired infections
1
. Systemic infections with multidrug-resistant enterococci occur subsequent to gastrointestinal colonization
2
. Preventing colonization by multidrug-resistant
E. faecalis
could therefore be a valuable approach towards limiting infection. However, little is known about the mechanisms
E. faecalis
uses to colonize and compete for stable gastrointestinal niches. Pheromone-responsive conjugative plasmids encoding bacteriocins are common among enterococcal strains
3
and could modulate niche competition among enterococci or between enterococci and the intestinal microbiota. We developed a model of colonization of the mouse gut with
E. faecalis
, without disrupting the microbiota, to evaluate the role of the conjugative plasmid pPD1 expressing bacteriocin 21 (ref.
4
) in enterococcal colonization. Here we show that
E. faecalis
harbouring pPD1 replaces indigenous enterococci and outcompetes
E. faecalis
lacking pPD1 |
---|---|
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/nature15524 |